TSN
42
2
MTCH
53
2
CVS
58
-2
ORLY
62
9
ECL
59
5
NWS
76
2
GLW
49
3
FTI
61
-5
FLS
55
3
AIV
51
3
CF
57
-2
D
48
3
EFX
50
3
TXN
65
-3
A
48
2
UAL
70
4
PHM
46
3
COST
44
-3
EQR
37
3
URBN
50
-9
TSN
42
2
MTCH
53
2
CVS
58
-2
ORLY
62
9
ECL
59
5
NWS
76
2
GLW
49
3
FTI
61
-5
FLS
55
3
AIV
51
3
CF
57
-2
D
48
3
EFX
50
3
TXN
65
-3
A
48
2
UAL
70
4
PHM
46
3
COST
44
-3
EQR
37
3
URBN
50
-9
Financhill
Back

Beam Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37

BEAM
Beam Therapeutics

Last Price:
$20.52
Seasonality Move:
-11.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Beam Therapeutics Stock Forecast

  • Over the next 52 weeks, Beam Therapeutics has on average historically risen by 25.3% based on the past 5 years of stock performance.
  • Beam Therapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%
  • Is Beam Therapeutics Stock Undervalued?
    The current Beam Therapeutics [BEAM] share price is $20.07. The Score for BEAM is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • BEAM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Beam Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Beam Therapeutics has on average historically risen by 25.3% based on the past 5 years of stock performance.

Beam Therapeutics Stock Rating

Sell
37
Beam Therapeutics (BEAM) is a Sell

Is Beam Therapeutics overpriced?

  • Beam Therapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%

Beam Therapeutics Stock Price History

Is BEAM stock going to rise?

  • The current trend is moderately bullish and BEAM is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
beamtx.com

52-Week Data

52-Week High:
35.25
52-Week Low:
13.53

Prediction Charts

Market Cap:
2B
Price in USD:
20.07
Volume:
2.1M
Beta:
1.80

Technical Analysis

SMA50:
17.87
SMA100:
19.97
SMA200:
22.88
52-Wk Change:
-26.46%

Stock Predictions

  • Is Beam Therapeutics stock public?
    Yes, Beam Therapeutics is a publicly traded company.
  • What is the Beam Therapeutics stock quote today?
    The Beam Therapeutics stock price is 20.07 USD today.
  • How to buy Beam Therapeutics stock online?
    You can buy Beam Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-26 16.80 17.14 17.23 16.49
Jun-27 17.32 16.80 17.51 16.75
Jun-30 17.00 17.01 17.73 16.86
Jul-1 16.85 17.53 18.23 16.59
Jul-2 17.66 19.88 20.15 17.66
Jul-3 20.20 20.01 20.46 19.57
Jul-7 19.85 19.18 20.05 19.02
Jul-8 19.37 20.30 20.71 19.28
Jul-9 21.76 21.46 22.39 20.86
Jul-10 22.51 22.03 22.51 21.04
Jul-11 21.73 21.16 22.19 20.95
Jul-14 21.12 21.17 21.75 20.75
Jul-15 21.34 19.58 21.69 19.40
Jul-16 19.76 20.07 20.51 19.66

Beam Therapeutics Earnings

Beam Therapeutics Earnings Report: Per Share Beam Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Beam Therapeutics Forecast Revenue Growth

Beam Therapeutics Stock Analysis: Historical quarterly revenues per share for Beam Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.18 per share, and an increase next year of $0.02 per share.

* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.